Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
This study has been completed.
Study NCT00001302   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Kidney Neoplasm
Lymphoma
Neoplasm Metastasis
Ovarian Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Kidney Neoplasms
Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Breast Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Immune System Diseases
Immunoproliferative Disorders
Kidney Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Neoplastic Processes
Ovarian Diseases
Pathologic Processes
Skin Diseases
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
PSC 833
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services